Werfen has agreed to sell its Medical Devices and Scientific Instrumentation Distribution businesses in Spain and Portugal to Palex for over €100 million, allowing Werfen to focus on specialized diagnostics while expanding Palex's position in the medical devices sector.

Target Information

Werfen has announced the sale of its Medical Devices and Scientific Instrumentation Distribution businesses in Spain and Portugal to Palex for an amount exceeding €100 million. This divestiture includes well-established entities such as Izasa Medical, Izasa Scientific, and MC Medical, which collectively contributed 7% to Werfen's total sales in 2023. In light of evolving market dynamics and strategic opportunities, Werfen's decision to refocus on its core business of specialized diagnostics necessitates this sale.

Industry Overview in Spain and Portugal

The medical device and scientific instrumentation industry in Spain and Portugal has been experiencing significant growth. With ongoing advancements in healthcare and technology, these markets have increasingly embraced innovative medical solutions. According to industry reports, the demand for modern healthcare equipment has surged, driven by an aging population and heightened healthcare expenditure.

Spain and Portugal form part of the Southern European healthcare landscape, characterized by strong government support for healthcare initiatives. Th

View Source

Similar Deals

Miura Partners Centro Psicosanitario Galiani and Orientak

2025

Other Private Equity Hospitals, Clinics & Primary Care Services Spain
Miura Partners Saesco Medical

2025

Other Private Equity Advanced Medical Equipment & Technology (NEC) Spain
Intellera PredictBy

2024

Other Private Equity Pharmaceuticals (NEC) Spain
Romano Senior DomusVi

2024

Other Private Equity Residential & Long-Term Care Spain
Agomab Therapeutics NV Origo Biopharma S.L.

2021

Other Private Equity Bio Therapeutic Drugs Spain

Palex

invested in

Werfen's Medical Devices and Scientific Instrumentation Distribution businesses

in 2024

in a Other Private Equity deal

Disclosed details

Transaction Size: $108M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert